Literature DB >> 4078599

Metrizamide and the EEG: three case reports and a review.

M Elian, P Fenwick.   

Abstract

Three patients are described who developed cerebral complications and an EEG abnormality for several days after metrizamide myelography. Clinically, the patients showed a fluctuating confusional state with dysphasia and retrograde amnesia, while their EEGs were dominated by runs of slow wave activity interspersed with frequent spikes. The runs appeared either continuously or in paroxysmal bursts. The clinical symptoms and the EEG are compatible with complex partial status epilepticus and are similar to the symptomatology of ten patients described in the literature. This rare clinical entity should be distinguished from a more common complication of metrizamide--non-specific slow wave abnormality of variable degree in the EEG with or without clinical signs. Clinical manifestations may include transient aphasia and weakness of the limbs with pyramidal signs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4078599     DOI: 10.1007/BF00313832

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  Methiodal sodium and metrizamide in lumbar myelography.

Authors:  T Hindmarsh
Journal:  Acta Radiol Suppl       Date:  1973

2.  The effect of metrizamide on the electroencephalogram: a prospective study in 61 patients.

Authors:  A H Ropper; K H Chiappa; R R Young
Journal:  Ann Neurol       Date:  1979-09       Impact factor: 10.422

3.  Adverse side effects of metrizamide and iopamidolo in myelography.

Authors:  A Carella; F Federico; F Di Cuonzo; E Vinjau; P Lamberti
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

4.  Electroencephalography (EEG) after introduction of water soluble contrast media into cerebrospinal fluid (CSF).

Authors:  H E Nau
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

5.  Confusion, myoclonus and speech arrest: epileptic manifestations after metrizamide myelography.

Authors:  U Bergvall; T Brismar; U Lying-Tunell; E Valdimarsson
Journal:  Acta Neurol Scand       Date:  1981-05       Impact factor: 3.209

6.  Transient encephalopathy and asterixis following metrizamide myelography. Case report.

Authors:  B Chehrazi; C Virapongse
Journal:  J Neurosurg       Date:  1981-11       Impact factor: 5.115

7.  EEG disturbances following myelography, cisternography and ventriculography with metrizamide.

Authors:  A Lundervold; O Sortland
Journal:  Acta Radiol Suppl       Date:  1977

8.  Competitive inhibition of brain hexokinase by metrizamide.

Authors:  J M Bertoni; C G Steinman
Journal:  Neurology       Date:  1982-03       Impact factor: 9.910

9.  Complex partial status epilepticus following myelography with metrizamide.

Authors:  D Russell; I M Anke; R Nyberg-Hansen; O Slettnes; O Sortland; T Veger
Journal:  Ann Neurol       Date:  1980-09       Impact factor: 10.422

10.  Asterixis and encephalopathy following metrizamide myelography: investigations into possible mechanisms and review of the literature.

Authors:  J M Bertoni; R J Schwartzman; G Van Horn; J Partin
Journal:  Ann Neurol       Date:  1981-04       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.